|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2009-4-13
|
|
pubmed:abstractText |
In previous studies, razoxane and vindesine together with radiotherapy was proved to be effective in soft tissue sarcomas (STS). Because razoxane leads to a redifferentiation of pathological tumor blood vessels, it was of particular interest to study the influence of this drug combination in vascular soft tissue sarcomas.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1879-355X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
74
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
187-91
|
|
pubmed:meshHeading |
pubmed-meshheading:19004568-Aged,
pubmed-meshheading:19004568-Drug Administration Schedule,
pubmed-meshheading:19004568-Female,
pubmed-meshheading:19004568-Hemangiopericytoma,
pubmed-meshheading:19004568-Hemangiosarcoma,
pubmed-meshheading:19004568-Humans,
pubmed-meshheading:19004568-Male,
pubmed-meshheading:19004568-Middle Aged,
pubmed-meshheading:19004568-Radiation-Sensitizing Agents,
pubmed-meshheading:19004568-Radiotherapy Dosage,
pubmed-meshheading:19004568-Razoxane,
pubmed-meshheading:19004568-Vindesine
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Treatment of vascular soft tissue sarcomas with razoxane, vindesine, and radiation.
|
|
pubmed:affiliation |
Department of Radiooncology, Academic Teaching Hospital, Feldkirch, Austria.
|
|
pubmed:publicationType |
Journal Article,
Multicenter Study,
Clinical Trial, Phase II
|
